Andrew King

Chief Tech/Sci/R&D Officer at JADE BIOSCIENCES, INC.

46 year

Health Technology

Consumer Services

Profile

Dr. Andrew King is a President-Research & Development at Jade Biosciences, Inc. and a Chief Scientific Officer at Jade Biosciences, Inc. (United States).
Dr. King was previously employed as a Chief Scientific Officer by Chinook Therapeutics, Inc. and a Senior Director-Discovery & Translational Biology by Ardelyx, Inc. He received his undergraduate degree from Murdoch University and a doctorate degree from Michigan State University.

Andrew King active positions

Companies	Position	Start
JADE BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	28/04/2025

All active positions of Andrew King

Former positions of Andrew King

Companies	Position	End
CHINOOK THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	09/08/2023
ARDELYX, INC.	Corporate Officer/Principal	-

See the detail of Andrew King's experience

Training of Andrew King

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew King's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Michigan State University Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Murdoch University Murdoch University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ardelyx, Inc. Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases	Health Technology
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services	Health Technology
Chinook Therapeutics, Inc. Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases	Health Technology